# Safety and Tolerability Trial of Microbial Inulinase

> **NCT05744700** · NA · COMPLETED · sponsor: **BIO-CAT, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Digestive Health
- Gastrointestinal Health

## Interventions

- **DIETARY_SUPPLEMENT:** Inulinase
- **DIETARY_SUPPLEMENT:** Maltodextrin placebo

## Key facts

- **NCT ID:** NCT05744700
- **Lead sponsor:** BIO-CAT, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-28
- **Primary completion:** 2023-10-06
- **Final completion:** 2023-10-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05744700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05744700, "Safety and Tolerability Trial of Microbial Inulinase". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05744700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*